Becton Dickinson and

Yahoo Finance • yesterday

ClearBridge Value Strategy adds AMZN, TSM, CRM, exits INTC, ABBV, EXPE among Q3 moves

The ClearBridge Value Strategy underperformed in its Russell 1000 Value Index benchmark in the third quarter, despite positive contributions from six out of the 11 sectors in which it was invested. The ClearBridge Value Strategy, in its f... Full story

Yahoo Finance • 2 days ago

Here's How You Can Earn $100 In Passive Income By Investing In Becton Dickinson Stock

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Becton, Dickinson and Co. (NYSE:BDX) is a multinational medical technology company that manufactures and sells medical devices, instrumen... Full story

Yahoo Finance • 6 days ago

Recursion Pharmaceuticals (RXRX) Shares Cross Above 200 DMA

In trading on Wednesday, shares of Recursion Pharmaceuticals Inc (Symbol: RXRX) crossed above their 200 day moving average of $5.83, changing hands as high as $5.89 per share. Recursion Pharmaceuticals Inc shares are currently trading up... Full story

Yahoo Finance • 18 days ago

5 Dividend Growth Stocks With Upside To Analyst Targets

To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years. Companies with this kind of track record tend to att... Full story

Yahoo Finance • 19 days ago

Oracle initiated, Ulta Beauty upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Argus upgraded Ulta Beauty(ULTA) to Bu... Full story

Yahoo Finance • 24 days ago

Becton, Dickinson and Company (BDX): A Healthcare Leader Among Cheap Dividend Stocks

Becton, Dickinson and Company (NYSE:BDX) is included among the 13 Incredibly Cheap Dividend Stocks to Invest in.Is Becton, Dickinson, and Company (BDX) the Best-Falling Stock to Buy According to Analysts? Becton, Dickinson and Company (NY... Full story

Yahoo Finance • 25 days ago

Fluorescence Cell Market Forecasts USD 6.37 Billion by 2034 at 7.29% CAGR

Ottawa, Sept. 19, 2025 (GLOBE NEWSWIRE) -- The global fluorescence cell market size is estimated at USD 3.17 billion in 2024 and has grown to USD 3.4 billion in 2025. It is projected to reach approximately USD 6.37 billion by 2034, expan... Full story

Yahoo Finance • 25 days ago

Biobanking Market Analysis and Forecast Report 2025-2035: Ethical and Legal Challenges in Biobanking - Navigating Consent and Privacy

Company Logo Driven by demand for personalized medicine and rising chronic diseases, the biobanking market faces ethical and regulatory challenges. Major players include Becton, Dickinson and Company, QIAGEN N.V., and Merck KGaA. Trends l... Full story

Yahoo Finance • 27 days ago

BD Marks 1,000th BD Rhapsody System, Driving Scientific Breakthroughs via Single-Cell Multiomics

FRANKLIN LAKES, N.J., Sept. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the placement of the 1,000th BD Rhapsody™ System, a flagship instrument for single-... Full story

Yahoo Finance • 28 days ago

Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business

From left: Jeffrey Chen, Vice President, BD (Becton Dickinson) Greater Asia; Yoo Young-ho, President, Celltrion Pharm; and Jason Hwang, Country General Manager, BD Korea, at the trilateral agreement signing ceremony. Strengthen the PFS CM... Full story

Yahoo Finance • 29 days ago

Peter Lynch Detailed Fundamental Analysis - BDX

Below is Validea's guru fundamental report for BECTON DICKINSON AND CO (BDX). Of the 22 guru strategies we follow, BDX rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks f... Full story

Yahoo Finance • last month

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Opendoor Technologies Inc. 136,631,575 7.32 6.86 6.875 +0.225 Eightco Ho... Full story

Yahoo Finance • 2 months ago

Elfun Trusts Exits Merck & Co Inc, Impacting Portfolio by -1.85%

This article first appeared on GuruFocus. Exploring Elfun Trusts (Trades, Portfolio)' Strategic Moves in Q2 2025 Take a short quiz to get matched with a financial advisor who understands your goals - no pressure, just real support. Elfu... Full story

Yahoo Finance • 2 months ago

Noteworthy ETF Outflows: TCAF, PTC, BDX, ROP

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the T. Rowe Price Capital Appreciation Equity ETF (Symbol: TCAF) where we have detected an approximate $278.1 mil... Full story

Yahoo Finance • 2 months ago

[Latest] Global Chemical Reagents Market Size/Share Worth USD 26.5 Billion by 2034 at a 7.5 CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Chemical Reagents Market size & share revenue was valued at approximately USD 14.1 B... Full story

Yahoo Finance • 2 months ago

Cell Cryopreservation Market Size to Expand USD 77.52 Bn by 21.05% CAGR till 2034

Ottawa, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Towards Healthcare, a sister firm of Precedence Research, reports that the global cell cryopreservation market reached USD 11.48 billion in 2024 and is projected to grow to approximately USD 77.5... Full story

Yahoo Finance • 2 months ago

MS Global Franchise Portfolio Exits UnitedHealth Group Inc, Impacting Portfolio by -3.33%

This article first appeared on GuruFocus. Insightful Moves in the Second Quarter of 2025 MS Global Franchise Portfolio (Trades, Portfolio) recently submitted its N-PORT filing for the second quarter of 2025, shedding light on its strateg... Full story

Yahoo Finance • 2 months ago

Top Buys by Directors: Hayes's $1M Bet on BDX

The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earne... Full story

Yahoo Finance • 2 months ago

Health care stocks with the largest net increases in hedge fund popularity – Goldman Sachs

[Medical industry stock market graph chart] Rasi Bhadramani Hedge funds increased their overweight positioning in health care (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]) despite a 7% decline in the sector during the second quarte... Full story

Yahoo Finance • 2 months ago

T. Rowe Price Capital Appreciation Equity ETF Experiences Big Inflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the T. Rowe Price Capital Appreciation Equity ETF (Symbol: TCAF) where we have detected an approximate $395.3 mil... Full story